Skip to content

Clinical trials

Phase 1 Pancreatic Neoplasms trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Phase: Phase 1 Country / region: Belgium Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20101
20133
20162
20172
20181
20201
20211
20221
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting4
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
Novartis Pharmaceuticals2
University Hospital, Ghent2
ADC Therapeutics S.A.1
Amgen1
Bayer1
Boehringer Ingelheim1
Exelixis1
Jean-Luc Van Laethem1
Jules Bordet Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms16
Carcinoma, Non-Small-Cell Lung5
Colorectal Neoplasms5
Triple Negative Breast Neoplasms5
Breast Neoplasms4
Cholangiocarcinoma4
Ovarian Neoplasms4
Stomach Neoplasms4
Esophageal Neoplasms3
Colonic Neoplasms2

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.